guaifenesin has been researched along with Chlamydia Infections in 6 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Chlamydia Infections: Infections with bacteria of the genus CHLAMYDIA.
Excerpt | Relevance | Reference |
---|---|---|
"An investigation was carried out to determine the therapeutic effect of levofloxacin (LVFX) once-a-day oral therapy at the dose of 200 mg/day for 7 days on uterine cervicitis, in comparison with LVFX twice-a-day oral therapy at the dose of 200 mg/day for 7 days." | 9.09 | [Effects of levofloxacin once-a-day therapy on uterine cervicitis]. ( Hayasaki, Y; Ito, K; Izumi, K; Kawazoe, K; Mikamo, H; Sato, Y; Tamaya, T; Yamada, Y, 1999) |
"An investigation was carried out to determine the therapeutic effect of levofloxacin (LVFX) once-a-day oral therapy at the dose of 200 mg/day for 7 days on uterine cervicitis, in comparison with LVFX twice-a-day oral therapy at the dose of 200 mg/day for 7 days." | 5.09 | [Effects of levofloxacin once-a-day therapy on uterine cervicitis]. ( Hayasaki, Y; Ito, K; Izumi, K; Kawazoe, K; Mikamo, H; Sato, Y; Tamaya, T; Yamada, Y, 1999) |
"Chlamydia infections are common causes of respiratory disease, particularly pneumonia in neonates, and are linked to permanent reductions in pulmonary function and the induction of asthma." | 1.40 | Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease. ( Collison, AM; Essilfie, AT; Foster, PS; Hansbro, PM; Hatchwell, LM; Horvat, JC; Kim, RY; Mattes, J; Nguyen, DH; Starkey, MR; Yagita, H, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Starkey, MR | 1 |
Nguyen, DH | 1 |
Essilfie, AT | 1 |
Kim, RY | 1 |
Hatchwell, LM | 1 |
Collison, AM | 1 |
Yagita, H | 1 |
Foster, PS | 1 |
Horvat, JC | 1 |
Mattes, J | 1 |
Hansbro, PM | 1 |
Miller, A | 1 |
Bromhead, C | 1 |
Jones, M | 1 |
Tustin, P | 1 |
Han, X | 2 |
Wang, S | 2 |
Fan, Y | 2 |
Yang, J | 2 |
Jiao, L | 1 |
Qiu, H | 1 |
Yang, X | 2 |
Mikamo, H | 1 |
Sato, Y | 1 |
Hayasaki, Y | 1 |
Tamaya, T | 1 |
Yamada, Y | 1 |
Ito, K | 1 |
Izumi, K | 1 |
Kawazoe, K | 1 |
Bilenki, L | 1 |
Winter, J | 1 |
Beer, J | 1 |
Marwitz, H | 1 |
1 trial available for guaifenesin and Chlamydia Infections
Article | Year |
---|---|
[Effects of levofloxacin once-a-day therapy on uterine cervicitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Chlamydia Infections; Drug Administration Schedule; | 1999 |
5 other studies available for guaifenesin and Chlamydia Infections
Article | Year |
---|---|
Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease.
Topics: Animals; Animals, Newborn; Antibodies, Neutralizing; Apoptosis; Chlamydia Infections; Chlamydia muri | 2014 |
Mucus digestion improves the detection of Chlamydia trachomatis and Neisseria gonorrhoeae on the cobas 4800.
Topics: Chlamydia Infections; Chlamydia trachomatis; Female; Gene Amplification; Gonorrhea; Humans; Male; Mu | 2012 |
Chlamydia infection induces ICOS ligand-expressing and IL-10-producing dendritic cells that can inhibit airway inflammation and mucus overproduction elicited by allergen challenge in BALB/c mice.
Topics: Allergens; Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Separation; Cells, Cultur | 2006 |
Chlamydia trachomatis infection inhibits airway eosinophilic inflammation induced by ragweed.
Topics: Allergens; Animals; Asteraceae; Chemokines; Chlamydia Infections; Chlamydia trachomatis; Cytokines; | 2002 |
[Significance of Bedsonia in respiratory diseases in calves and young cattle].
Topics: Age Factors; Animals; Antibodies; Cattle; Cattle Diseases; Chick Embryo; Chlamydia; Chlamydia Infect | 1970 |